OP0264 COST-UTILITY OF A PROGRESSIVE SPACING OF TOCILIZUMAB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SUSTAINED REMISSION: A MEDICO-ECONOMIC ANALYSIS OF THE TOLEDO TRIAL

التفاصيل البيبلوغرافية
العنوان: OP0264 COST-UTILITY OF A PROGRESSIVE SPACING OF TOCILIZUMAB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SUSTAINED REMISSION: A MEDICO-ECONOMIC ANALYSIS OF THE TOLEDO TRIAL
المؤلفون: Kedra, J., Granger, B., EL Houari, L., Tubach, F., Fautrel, B.
المصدر: Scientific Abstracts ; page 174.2-175
بيانات النشر: BMJ Publishing Group Ltd and European League Against Rheumatism
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/annrheumdis-2023-eular.4115
الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2023-eular.4115
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.4115
رقم الانضمام: edsbas.BF027E02
قاعدة البيانات: BASE
الوصف
DOI:10.1136/annrheumdis-2023-eular.4115